Medical University of Warsaw

  • DATABASE (2789)

  • ARTICLES (812)

    • DATABASE (2789)
    • ARTICLES (812)
  • Sort by
    • Relevance
    • Date

Lei Ming graduated from Peking University (PKU) with a master's degree in Computer Science. While at university, he was a member of the PKU Sky Network search engine program. In 2000, Lei became one of the seven founding members of Baidu, where he led the search engine design and development team. Lei received his MBA from Stanford Business School in 2003. In 2005, he returned to China and started Kuwo Music, now one of the largest music platforms in China. As an angel investor, Lei focuses on the sectors of AI, consumption, education, medical services and entertainment.

Gem Flower Healthcare was set up by state-owned China National Petroleum Corporation in March 2017 as a healthcare business platform and medical services group. Today, the healthcare group owns over 300 medical institutions, including 10 top-tier grade hospitals in China. Gem Flower Healthcare manages about 20,000 hospital beds and generates annual revenues of about RMB 10bn.

Guillem Ysàs Miralles holds a degree in Computer Science from the Autonomous University of Barcelona and is currently lead programmer for the Atomian cognitive core technology. He was one of the developers of the Atomian (product) architecture and the Atomian Modeling Language (AML). He is also lead programmer for Atomian's medical products and is responsible for Atomian's ETL software. He previously worked as analyst and web developer at Elecnor and Teytel, as a first level operator in NextReT and as a Specialist in B. Braun Medical. 

Self-confessed geek and chess lover João Pedro Ribeiro holds a master’s degree in Biomedical/Medical Engineering from the University of Minho. His master’s thesis project in developing a 3D modeling application for orthopedic surgeons became the base of PeekMed.

Easo Ventures is a Spanish early-stage VC established in 2018 in the Basque city of San Sebastian, offering selected companies either €50,000 or €100,000 according to their development stage. It currently has 29 companies in its portfolio across verticals and technologies, but all must be based in Spain. Its most recent investments include the €2m seed round of medtech IOMED Medical Solutions, which converts medical text into extractable data, and the €1.2m post-seed round of drone company Alerion. 

A co-founder and angel investor of HomeRun, Cheng Xiaohua graduated with a major in Automation at Changsha Railway University in 1983. The university is now known as Railway Campus, Central South University. From 1984 to 1988, he spent his postgraduate years at Graduate School, University of Chinese Academy of Sciences and earned a master’s degree in Automation. He co-founded Netac with Deng Guoshun in 1999 and became the chairman in September 2010.

Founded in 2017, Suzhou Longmen Ventures mainly invests in businesses working on innovative drugs and medical devices. It manages tens of billions RMB in assets. 

“I want to change the world!” says Sara Silva in her LinkedIn profile. She might just do that, as co-founder of PeekMed, a 3D imaging software that is potentially revolutionizing orthopedic surgery. Silva holds a master’s in Biomedical/Medical Engineering from the University of Minho.

Freire Rodrigues is the Portuguese co-founder and CEO at UpHill, whose SaaS helps healthcare professionals keep up-to-speed on the latest clinical treatments and protocols using AI. He also continues to be an invited assistant teacher at Lisbon’s NOVA Medical School’s Faculty of Medical Sciences, where he completed a master’s in Medicine and worked full-time for three years prior to UpHill. He additionally collaborates in public healthcare at the ARSLVT healthcare company in Lisbon. He has worked as a resident physician at public hospitals in Lisbon and Paris.Freire Rodrigues also completed clinical scholars research training at Harvard Medical School and gained a qualification in Information Management and Business Intelligence in Healthcare at NOVA Information Management School in Lisbon.

Founded by Li Shujun, the former CFO of Shengda, in 2006, Trustbridge Partners is a venture capital and private equity firm focusing on growth-stage and expansion-stage investments in Chinese companies in new energy, environmental protection, new materials, new media, retailing, healthcare, education, e-commerce, etc. The sources of its funds come mainly from university foundations in the US (such as Columbia University, Stanford University, New York University), world-renowned investment firms (Temasek Holdings, Kerry Group, etc.), and private investors.

Olivier Clatz is the French co-founder of AI medical diagnosis company Therapixel, creator of MammoScreen breast cancer screening and diagnosis tool. Prior to co-founding Therapixel, Clatz worked for six years as a research scientist at INRIA (National Institute for Research in Digital Science and Technology) based at the Sophia Antipolis technology park near Antibes, in the south of France. His later work with INRIA focused on exploiting machine learning algorithms for medical imaging processing. Prior to this, he was a research associate at Harvard Medical School, in the US. In 2006, he completed his PhD at INRIA on the concept of personalized medicine. Clatz also holds a PhD in philosophy from the Ecole des Mines de Paris, and a master's degree in applied mathematics from the Ecole Normale Supérieure Paris-Saclay. Currently, he works at the French Government’s Commissariat Générale pour l’Investissement managing the national program AI For Diagnostics. He left Therapixel in 2019.

Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas. 

Huaxin Capital is a private equity fund management platform that was set up by Luxin Venture Capital Group in 2011. Huaxin Capital invests in the fields of biomedicine, medical equipment, internet, IoT, clean energy, high-end equipment manufacturing, among others. 

Inspired by community-supported agriculture (CSA), Thousands of Farmers provides an e-commerce platform enabling consumers to subscribe to farm harvests in advance and share their profits. 

Shuai Ke graduated from Jiangsu University in 2006 with a bachelor’s degree in Medical Insurance. Upon graduation, he joined Colgate to work in marketing and sales. Two years later, he joined news portal NetEase. In April 2014, he resigned from the post of editor-in-chief for the tech channel at NetEase and co-founded Fenbi, the predecessor of Yuanfudao. 

Sorry, we couldn’t find any matches for “Medical University of Warsaw”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.